Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Lumos Pharma
>>
Phase 2
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
2
4
6
8
10
12
14
16
18
20
indoximod
(NLG8189) / Lumos Pharma
davamotecan pegadexamer
(EP0057) / Ellipses Pharma
Oratrope
(ibutamoren) / Merck (MSD), Lumos Pharma
INGN 225
/ Lumos Pharma
HyperAcute Melanoma
(dorgenmeltucel-L) / Lumos Pharma
docetaxel-loaded nanopharmaceutical
(CRLX301) / Ellipses Pharma
